Wallberg B, Michelson H, Nystedt M, Bolund C, Degner L F, Wilking N
Department of Clinical Oncology, Karolinska Hospital, Stockholm, Sweden.
Acta Oncol. 2000;39(4):467-76. doi: 10.1080/028418600750013375.
Patient participation in treatment decisions presupposes well-informed patients. The purpose of this study was to determine Swedish breast cancer patients' information needs and their preferences for participation in treatment decisions. Patients (n = 201) were interviewed on nine categories of information and five patient roles, using paired comparisons. Patients gave priority to facts about disease and treatment (chances of cure, stage of disease, treatment options). A collaborative role in treatment decisions was preferred by 87% of the patients. Most patients (56%) preferred a passive form of collaboration: I prefer that my doctor makes the final decision about my treatment but seriously considers my opinion. Younger and better educated patients tended to prefer a more active role. Many patients wanted to be more active (20%) and some more passive (8%) than they actually were. Patients gave priority to disease-specific information, but this reflected needs other than taking control of treatment decisions.
患者参与治疗决策的前提是患者充分知情。本研究的目的是确定瑞典乳腺癌患者的信息需求以及他们对参与治疗决策的偏好。采用配对比较法,对201名患者就九类信息和五种患者角色进行了访谈。患者将疾病和治疗方面的事实(治愈几率、疾病阶段、治疗选择)列为优先考虑的信息。87%的患者倾向于在治疗决策中发挥协作作用。大多数患者(56%)倾向于一种被动的协作形式:我希望我的医生对我的治疗做出最终决定,但要认真考虑我的意见。年龄较小和受教育程度较高的患者往往倾向于发挥更积极的作用。许多患者希望比实际表现得更积极(20%),还有一些患者希望更消极一些(8%)。患者将特定疾病信息列为优先考虑的内容,但这反映的需求并非控制治疗决策。